These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25474387)
1. A fatal case of systemic lupus erythematosus complicated by macrophage activation syndrome, portal vein thrombosis and acute colitis. Ma Y; Reddy V; Reilly S Int J Rheum Dis; 2017 Nov; 20(11):1805-1807. PubMed ID: 25474387 [No Abstract] [Full Text] [Related]
2. Systemic lupus erythematosus presenting to haematology with pancytopenia and features of macrophage activation syndrome. Mistry J; Knee G; Jayakar V BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29467122 [No Abstract] [Full Text] [Related]
3. [Thrombocytosis in a macrophage activation syndrome complicating systemic lupus erythematosus]. Lekpa FK; Ndongo S; Fall S; Pouye A; Ka MM; Moreira-Diop T Pan Afr Med J; 2014; 19():11. PubMed ID: 25584123 [TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report. Fioravante da Silveira L; Zago A; Zanchet D; Chemello D Reumatismo; 2023 Jul; 75(2):. PubMed ID: 37462126 [TBL] [Abstract][Full Text] [Related]
5. Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children. Gokce M; Bilginer Y; Besbas N; Ozaltin F; Cetin M; Gumruk F; Ozen S Lupus; 2012 Jul; 21(8):878-84. PubMed ID: 22495873 [TBL] [Abstract][Full Text] [Related]
6. Macrophage activation syndrome as a presenting feature in juvenile systemic lupus erythematosus. Ramadoss I; Rengabashyam P; Seetharaman Varadhan M; Ponniah Subramanian AR Lupus; 2024 Oct; 33(11):1254-1259. PubMed ID: 39109623 [TBL] [Abstract][Full Text] [Related]
7. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus. Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230 [No Abstract] [Full Text] [Related]
8. Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus. Junga Z; Stitt R; Tracy C; Keith M BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28827301 [TBL] [Abstract][Full Text] [Related]
9. A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report. Hali F; Jabri H; Chiheb S; Hafiani Y; Nsiri A Int J Dermatol; 2021 Aug; 60(8):1030-1031. PubMed ID: 33864388 [No Abstract] [Full Text] [Related]
10. [Hemorrhagic syndrome due to a heparin-like anticoagulant in a patient with systemic lupus erythematosus]. Ratti N; Cypierre A; Bezanahary H; Gondran G; Le Coustumier E; Palat S; Nadalon S; Liozon E; Ly K; Fauchais AL Rev Med Interne; 2019 Mar; 40(3):184-187. PubMed ID: 30471875 [TBL] [Abstract][Full Text] [Related]
11. Portal vein thrombosis in systemic lupus erythematosus associated with anticardiolipin antibodies. Cavallasca JA; Musuruana JL; Granero G Int J Rheum Dis; 2011 Feb; 14(1):e5-7. PubMed ID: 21303473 [No Abstract] [Full Text] [Related]
12. Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report. Funada M; Nakano K; Miyagawa I; Ueno M; Tanaka Y Mod Rheumatol Case Rep; 2020 Jul; 4(2):229-232. PubMed ID: 33087014 [TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center. Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044 [TBL] [Abstract][Full Text] [Related]
14. Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus. Usami M; Shimizu M; Mizuta M; Inoue N; Irabu H; Sakumura N; Nakagishi Y; Yachie A Clin Immunol; 2019 Nov; 208():108255. PubMed ID: 31476438 [TBL] [Abstract][Full Text] [Related]
15. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus. Aoyama-Maeda N; Horino T; Ichii O; Terada Y Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692 [TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide. Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795 [TBL] [Abstract][Full Text] [Related]